Kedoya Adyaraya (IDX:RSGK) - Stock Price, News & Analysis

RSGK Stock Overview

Owns and operates hospitals in Indonesia.

RSGK fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	4/6
Financial Health	6/6
Dividends	2/6

Rewards

Price-To-Earnings ratio (29.4x) is below the Healthcare industry average (35.8x)

Earnings grew by 14% over the past year

Risk Analysis

Earnings have declined by 4.5% per year over past 5 years

Does not have a meaningful market cap (IDR1,074B)

Dividend of 1.92% is not well covered by free cash flows

PT Kedoya Adyaraya Tbk Competitors

Bundamedik

IDX:BMHS

Rp2.5t

Famon Awal Bros Sedaya

IDX:PRAY

Rp8.7t

Medikaloka Hermina

IDX:HEAL

Rp20.8t

Mitra Keluarga Karyasehat

IDX:MIKA

Rp38.0t

Price History & Performance

Summary of all time highs, changes and price drops for Kedoya Adyaraya
Historical stock prices
Current Share Price	Rp1,145.00
52 Week High	Rp1,410.00
52 Week Low	Rp795.00
Beta	0.11
11 Month Change	-6.91%
3 Month Change	25.82%
1 Year Change	-10.20%
33 Year Change	-33.04%
5 Year Change	n/a
Change since IPO	-46.74%

Recent updates

Shareholder Returns

	RSGK	ID Healthcare	ID Market
7D	-4.6%	-1.4%	-2.3%
1Y	-10.2%	24.8%	14.9%

Return vs Industry: RSGK underperformed the ID Healthcare industry which returned 26.8% over the past year.

Return vs Market: RSGK underperformed the ID Market which returned 15.9% over the past year.

Price Volatility

Is RSGK's price volatile compared to industry and market?
RSGK volatility
RSGK Average Weekly Movement	8.6%
Healthcare Industry Average Movement	5.1%
Market Average Movement	5.6%
10% most volatile stocks in ID Market	13.2%
10% least volatile stocks in ID Market	2.4%

Stable Share Price: RSGK has not had significant price volatility in the past 3 months compared to the ID market.

Volatility Over Time: RSGK's weekly volatility (9%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1990	719	Liem Hong	www.grhahospitals.com

PT Kedoya Adyaraya Tbk owns and operates hospitals in Indonesia. The company provides facilities, such as inpatient and outpatient room, operating room, delivery room, HCU, ICU, ICCU, PICU, NICU, emergency room, inpatient, outpatient, covid ICU isolation, endoscopy, operating room, sterilization service center installation, and delivery room. It also offers medical support services, including pharmacy, radiology, CT-Scan, mammography, mobile x-ray, general x-ray, 4D ultrasound, central sterile supply department, fluoroscopy unit, mobile C-Arm, bone densitometry, laparoscopy, bronchoscopy, catheterization laboratory, spirometry, audiometry, electroencephalography, electromyography, electrocardiogram, treadmill, echocardiography, hemodialysis, laser treatment, medical rehabilitation, trauma center, nutrition unit, medical record, panoramic, cephalometry, digital radiography, 4D USG, and 2D/3D USG, as well as laboratories for chemistry, hematology, hemostasis, microbiology, immune-serology, and biomolecular.

PT Kedoya Adyaraya Tbk Fundamentals Summary

How do Kedoya Adyaraya's earnings and revenue compare to its market cap?
RSGK fundamental statistics
Market cap	Rp1.07t
Earnings (TTM)	Rp36.25b
Revenue (TTM)	Rp419.13b

29.4x

P/E Ratio

2.5x

P/S Ratio

Is RSGK overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RSGK income statement (TTM)
Revenue	Rp419.13b
Cost of Revenue	Rp264.53b
Gross Profit	Rp154.60b
Other Expenses	Rp118.35b
Earnings	Rp36.25b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	39.00
Gross Margin	36.89%
Net Profit Margin	8.65%
Debt/Equity Ratio	0%

How did RSGK perform over the long term?

See historical performance and comparison

Dividends

1.9%

Current Dividend Yield

28%

Payout Ratio